Comparative effects on nocturnal hypertension at home by combination therapy of ARB/CCB and ARB/diuretics

Trial Profile

Comparative effects on nocturnal hypertension at home by combination therapy of ARB/CCB and ARB/diuretics

Completed
Phase of Trial: Phase III

Latest Information Update: 31 May 2017

At a glance

  • Drugs Amlodipine/irbesartan (Primary) ; Irbesartan/trichlormethiazide (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms NOCTURNE
  • Most Recent Events

    • 29 Sep 2016 Status changed from active, no longer recruiting to completed, as per results presented at the 26th Scientific Meeting of the International Society of Hypertension
    • 29 Sep 2016 Preliminary results presented at the 26th Scientific Meeting of the International Society of Hypertension
    • 25 May 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top